Skip to main content

Table 1 Relationship between clinical features of pancreatic cancer and the miR-221-3p content in TCGA dataset

From: MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value

Characteristics N M ± SD p
Tissues
 Adjacent non-cancerous tissues 4 9.728 ± 0.6995 0.1568
 Pancreatic cancer 179 10.50 ± 1.073  
Age (years)
 < 60 55 10.85 ± 1.010 0.0027*
 ≥ 60 124 10.34 ± 1.066  
Gender
 Male 99 1.172 0.8089
 Female 80 0.9425  
Radiation therapy
 No 120 10.48 ± 1.147 0.7639
 Yes 44 10.54 ± 0.9448  
Smoking status
 No 120 10.57 ± 0.9689 0.1918
 Yes 59 10.35 ± 1.254  
Tumour location
 Pancreas 178 10.49 ± 1.076 0.0193*
 Metastasis 1 10.685  
Vital status
 Alive 86 10.36 ± 1.167 0.0989
 Dead 93 10.62 ± 0.9674  
Stage
 Stage I–II 168 10.49 ± 1.083 0.9691
 Stage III–IV 9 10.48 ± 0.7458  
T
 T1-T2 32 10.63 ± 1.321 0.4649
 T3-T4 146 10.47 ± 1.015  
N
 No 124 10.47 ± 1.023 0.7403
 Yes 54 10.53 ± 1.185  
M
 No 174 10.50 ± 1.083 0.8312
 Yes 5 10.39 ± 0.6852  
Residual tumour
 No 111 10.44 ± 1.194 0.389
 Yes 58 10.59 ± 0.8653  
  1. N indicates number, SD indicates standard deviation, M indicates mean, *indicates significant difference defined as p < 0.05